Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study

BACKGROUND: There is little evidence on the use of secondary prevention medicines for cardiovascular disease by socioeconomic groups in countries at different levels of economic development. METHODS: We assessed use of antiplatelet, cholesterol, and blood-pressure-lowering drugs in 8492 individuals...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Lancet Glob Health
Egile Nagusiak: Murphy, Adrianna, Palafox, Benjamin, O'Donnell, Owen, Stuckler, David, Perel, Pablo, AlHabib, Khalid F, Avezum, Alvaro, Bai, Xiulin, Chifamba, Jephat, Chow, Clara K, Corsi, Daniel J, Dagenais, Gilles R, Dans, Antonio L, Diaz, Rafael, Erbakan, Ayse N, Ismail, Noorhassim, Iqbal, Romaina, Kelishadi, Roya, Khatib, Rasha, Lanas, Fernando, Lear, Scott A, Li, Wei, Liu, Jia, Lopez-Jaramillo, Patricio, Mohan, Viswanathan, Monsef, Nahed, Mony, Prem K, Puoane, Thandi, Rangarajan, Sumathy, Rosengren, Annika, Schutte, Aletta E, Sintaha, Mariz, Teo, Koon K, Wielgosz, Andreas, Yeates, Karen, Yin, Lu, Yusoff, Khalid, Zatońska, Katarzyna, Yusuf, Salim, McKee, Martin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier Ltd 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5905400/
https://ncbi.nlm.nih.gov/pubmed/29433667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2214-109X(18)30031-7
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak